News
SenesTech Announces Third Quarter 2022 Financial Results
Product Sales up 57% year-over-year PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer
PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Financial results to be released before market open; Conference call to be conducted at 11:00 am ET PHOENIX, Nov. 9, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2022, ended September 30, 2022, before the market open on...
SenesTech to Participate in the Lytham Partners Fall 2022 Investor Conference
PHOENIX, Sept. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking...
SenesTech Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Intended to Facilitate a Reverse Stock Split, if Necessary PHOENIX, Aug. 26, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male...
SenesTech Announces Record Second Quarter 2022 Product Sales
Sales up 73% year-over-year and up 42% sequentially PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and...
ContraPest® Shows Dramatic Success in Zoo Deployments
PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest, today released further...
SenesTech to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 4, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2022, ended June 30, 2022, after the market close on...
Elevate Bait System™ with ContraPest® is Now Available in California
PHOENIX, Aug. 1, 2022 -- SenesTech, Inc., (SNES), the rodent fertility control experts, announced that its new Elevate Bait System™ with ContraPest®, the only EPA registered birth control for both male and female rats, is available for sale in all fifty...
Specifically Designed to Eliminate Roof Rats in Elevated Spaces – the New EPA-Registered Elevate Bait System™ with ContraPest® Is Now Available for Sale.
"Love is in the air" - a single pair of breeding rats can account for generations of rats; as many as 15,000 after just one year. ContraPest, the EPA-registered birth control for rats, can now be deployed in elevated indoor spaces to combat rising roof rat populations...